Last reviewed · How we verify
Nivolumab Injection [Opdivo]
At a glance
| Generic name | Nivolumab Injection [Opdivo] |
|---|---|
| Also known as | Nivolumab, nivo, carboplatin, paclitaxel, Opdivo |
| Sponsor | Tel-Aviv Sourasky Medical Center |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nivolumab Injection [Opdivo] CI brief — competitive landscape report
- Nivolumab Injection [Opdivo] updates RSS · CI watch RSS
- Tel-Aviv Sourasky Medical Center portfolio CI